Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Vanesa Agulló"'
Autor:
Javier García-Abellán, Marta Fernández, Sergio Padilla, José Alberto García, Vanesa Agulló, Valle Lozano, Nuria Ena, Lidia García-Sánchez, Félix Gutiérrez, Mar Masiá
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundThe pathophysiology of long-COVID remains unknown, and information is particularly limited for symptoms of very long duration. We aimed to assess the serological, T-cell immune responses and ANA titers of patients with long-COVID-19 syndrom
Externí odkaz:
https://doaj.org/article/1d8f9eb4f0ff4c5ca4d920790edf8c6f
Autor:
Mar Masiá, Marta Fernández-González, José Alberto García, Sergio Padilla, Javier García-Abellán, Ángela Botella, Paula Mascarell, Vanesa Agulló, Félix Gutiérrez
Publikováno v:
EBioMedicine, Vol 82, Iss , Pp 104153- (2022)
Summary: Background: Whether interleukin-6 (IL-6) blockade in patients with COVID-19 will affect the protective immunity against SARS-CoV-2 has become an important concern for anti-IL-6 therapy. We aimed to investigate the effects of IL-6 blockade on
Externí odkaz:
https://doaj.org/article/b3f7b82121e84e37938b1b8db5b4717e
Autor:
Mar Masiá, Marta Fernández-González, Sergio Padilla, Piedad Ortega, José A. García, Vanesa Agulló, Javier García-Abellán, Guillermo Telenti, Lucía Guillén, Félix Gutiérrez
Publikováno v:
EBioMedicine, Vol 60, Iss , Pp 102999- (2020)
Background: The virological and immunological effects of the immunomodulatory drugs used for COVID-19 remain unknown. We evaluated the impact of interleukin (IL)-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and the antibody response in pa
Externí odkaz:
https://doaj.org/article/a9491bb0f1bb4d49a487721fefb0fc6f
Autor:
Jara Llenas-García, Mar Masiá, Reyes Pascual Perez, Inmaculada González-Cuello, Vanesa Agulló Re, Mónica Romero Nieto, María Amat Díaz, Sergio Padilla Urrea, Francisco José Rodríguez Lucena, Philip Wikman-Jorgensen
Publikováno v:
AIDS Care. :1-9
We conducted a multicentre observational study in people living with HIV (PLHIV) on antiretroviral therapy in Alicante (Spain) from 2019 to 2020 aiming to analyse the prevalence of abuse and assess treatment adherence according to this variable. We u
Autor:
Mar Masiá, Marta Fernández-González, Vanesa Agulló, Paula Mascarell, Sergio Padilla, Javier García-Abellán, Félix Gutiérrez
Publikováno v:
Clinical Infectious Diseases. 76:e748-e751
Human immunodeficiency virus type 1 RNA levels were longitudinally evaluated in 211 rectal and 152 seminal samples from 12 virologically suppressed participants switching to monthly long-acting cabotegravir plus rilpivirine or continuing with daily d
Autor:
Sandra Ruiz, Mar Masiá, Sergio Padilla, Antonio Galiana, José A. García, Javier García-Abellán, Marta Fernández-González, María Andreo, Vanesa Agulló, Félix Gutiérrez
Publikováno v:
Journal of Clinical Immunology
Background The relationship of host immune response and viral replication with health outcomes in patients with COVID-19 remains to be defined. We aimed to characterize the medium and long-term clinical, virological, and serological outcomes after ho
Autor:
Mar Masiá, Marta Fernández-González, Nieves Gonzalo-Jiménez, Victoria Ortiz de la Tabla, Vanesa Agulló, Félix Gutiérrez, José A. García
Publikováno v:
Journal of Infection
The Journal of Infection
The Journal of Infection
Autor:
Marta Fernández-González, Vanesa Agulló, Sergio Padilla, José Alberto García, Javier García-Abellán, Ángela Botella, Paula Mascarell, Montserrat Ruiz-García, Mar Masiá, Félix Gutiérrez
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background We evaluated a standardized interferon-γ (IFN-γ) release assay (IGRA) for detection of T-cell immune response after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or vaccination. Methods This prospective study inc
Autor:
Javier García-Abellán, Vanesa Agulló, Marta Fernández-González, Félix Gutiérrez, Sergio Padilla, Mar Masiá, José A. García
Publikováno v:
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
BackgroundThe time at which the protective effect of starting ART is achieved in male rectal and genital reservoirs is not clearly established.ObjectivesTo quantify HIV-1 RNA decay towards virological suppression in rectal mucosa and semen in MSM sta
Autor:
Vanesa Agulló, Félix Gutiérrez, José A. García, Elena García-Payá, Javier García-Abellán, Marta Fernández-González, Mar Masiá, Ana Gutiérrez, Sergio Padilla, Victoria Ortiz de la Tabla
Publikováno v:
Clinical Infectious Diseases. 70:2161-2167
Background We aimed to assess the relationship between sexually transmitted infections (STIs)—including a large panel of human papillomavirus (HPV) genotypes—and high-grade anal intraepithelial neoplasia (HGAIN) in men who have sex with men (MSM)